Pliant Therapeutics (PLRX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ed ...
Enrollment has finished for the Phase 3 RISE UP study, which is testing the oral therapy mitapivat in people with sickle cell ...
Medicare vs. Medicare Advantage sales pitches are often from biased sources, the choices can be overwhelming, and impartial help is not equally available to all.
Pennie, Get Covered New Jersey insurance marketplaces are designed for people who do not have access to health insurance ...
October 29, 2024Announcement no. 20First Patient In - BioPorto Initiates Patient Enrollment for US Study of ProNephro AKI (NGAL)™ for Adult Use ...
In the LIFE-BTK trial, several initiatives were implemented to facilitate enrollment of diverse populations, ensuring that pati ...
WTIC Hartford on MSN7d
Access Health CT to host in-person events to help enroll in health insuranceAccess Health CT announced 10 events taking place throughout November to help those wanting to enroll for this coming year.
The Oklahoman on MSN11d
Over a million patients lose coverage as insurers and hospitals drop Medicare AdvantageFacing financial and federal regulatory pressures, many insurers are pulling their Medicare Advantage plans from counties and ...
People with FSHD, ages 16 to 70, enrolled in this Phase 1/2 FORTITUDE trial cohort will aid biomarker data to support early approval request.
Thrombolex, Inc. announced the commencement of enrollment in the RAPID-PE study, which uses the company’s Bashir endovasc ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback